Used as a key intermediate in Suzuki-Miyaura cross-coupling reactions for the synthesis of biologically active compounds, particularly in pharmaceutical development. Its boronate ester group enables efficient carbon-carbon bond formation under mild conditions. The presence of a trifluoroethoxy moiety enhances lipophilicity and metabolic stability in drug candidates, making this reagent valuable in the design of agrochemicals and medicinal agents targeting central nervous system disorders and oncology pathways. Commonly employed in late-stage functionalization due to its stability and reactivity profile.